- Accueil >
- Publications >
- CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute
Auteurs
G Zoppoli, S Solier, W C Reinhold, H Liu, J W Connelly, A Monks, R H Shoemaker, O D Abaan, S R Davis, P S Meltzer, J H Doroshow, Y Pommier
